Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Non-cash Items (2016 - 2025)

Historic Non-cash Items for BioRestorative Therapies (BRTX) over the last 15 years, with Q3 2025 value amounting to $3.8 million.

  • BioRestorative Therapies' Non-cash Items rose 6188.14% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 6188.14%. This contributed to the annual value of $2.5 million for FY2024, which is 10799.65% up from last year.
  • BioRestorative Therapies' Non-cash Items amounted to $3.8 million in Q3 2025, which was up 6188.14% from $3.6 million recorded in Q2 2025.
  • In the past 5 years, BioRestorative Therapies' Non-cash Items registered a high of $1.2 billion during Q1 2021, and its lowest value of $294658.0 during Q3 2021.
  • Moreover, its 5-year median value for Non-cash Items was $2.2 million (2024), whereas its average is $140.8 million.
  • In the last 5 years, BioRestorative Therapies' Non-cash Items skyrocketed by 2895687.79% in 2021 and then tumbled by 9995.49% in 2022.
  • Over the past 5 years, BioRestorative Therapies' Non-cash Items (Quarter) stood at $349237.0 in 2021, then skyrocketed by 2992.46% to $10.8 million in 2022, then plummeted by 88.87% to $1.2 million in 2023, then skyrocketed by 108.0% to $2.5 million in 2024, then surged by 52.29% to $3.8 million in 2025.
  • Its last three reported values are $3.8 million in Q3 2025, $3.6 million for Q2 2025, and $3.4 million during Q1 2025.